A case of “smoldering” immune‐mediated thrombotic thrombocytopenic purpura manifesting as recurrent cardioembolic stroke

A case of “smoldering” immune‐mediated thrombotic thrombocytopenic purpura manifesting as recurrent cardioembolic stroke

Abstract Prompt recognition and treatment for thrombotic thrombocytopenic purpura (TTP) are critical to prevent the irreversible manifestations of this rare and quickly fatal hematologic disorder. Untreated TTP is typically a rapid‐onset disease with mortality exceeding 90% within days in the absenc...

Full description

Bibliographic Details
Main Authors: Mark E. Pepin, Eyad Saca, Soo Y. Kwon, Jori May
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Clinical Case Reports
Subjects:
adalimumab
microangiopathy
thromboembolic stroke
thrombotic thrombocytopenic purpura
Online Access:https://doi.org/10.1002/ccr3.4850

Internet

https://doi.org/10.1002/ccr3.4850

Similar Items